Do Bioimpedance Measurements of Over-Hydration Accurately Reflect Post-Haemodialysis Weight Changes? by Tangvoraphonkchai, K & Davenport, A
 1 
Do bioimpedance measurements of over-hydration accurately reflect post-
haemodialysis weight changes ? 
 
 
1Kamonwan Tangvoraphonkchai MD, 2Andrew Davenport  FRCP 
 
1Faculty of Medicine, Mahasarakham University,Maha Sarakham, Thailand 
2UCL Centre for Nephrology, Royal Free Hospital, University College London 
Medical School, London NW3 2PF, UK 
 
Kamonwan Tangvoraphonkchai kamonwan.tangvoraphonkchai@nhs.net 
Andrew Davenport   andrewdavenport@nhs.uk 
  
 
Address for correspondence 
Andrew Davenport   andrewdavenport@nhs.net 
 
 
contact andrewdavenport@nhs.net 
UCL Centre for Nephrology, Royal Free Hospital, University College London 
Medical School, Rowland Hill Street, London NW3 2PF 
tel 44-2074726457 fax 44-2073178591 
 
 
short title change in bioimpedance hydration index following haemodialysis  
 
 
key words bioimpedance   haemodialysis  hydration total body 
water  extracellular water  intracellular water    
 
 
 
 
word count abstract 223 
  body  2557 
  figures  3 
tables  2 
  references 31 
 
Funding  Royal Free Hospital  
Dr K Tangvoraphonkchai was awarded an ISN scholarship. 
Neither author has any conflict of interest 
 2 
Abstract 
Introduction 
Bioimpedance spectroscopy (BIS) devices are being used to determine 
ultrafiltration requirements to achieve target weight for haemodialysis (HD) 
patients. Pre-dialysis measurements are more convenient for patients and staff. 
We wished to compare the changes in pre-and post-dialysis hydration measured 
by BIS with actual weight loss. 
Methods 
We compared paired BIS measurements made pre and post-haemodialysis 
using a BIS device based on a 3 compartmental model, designed to provide 
information on extracellular water (ECW) excess . 
Results 
 BIS was measured in 49 HD patients, 35 male (71.4%), mean age 67.6 
±14.2 years. Weight fell significantly from 69.2±17.8 to 67.6±17.4 kg, and BIS 
over hydration (OH) from 4.5±3.3.4 to 3.4±2.9 L, and ECW from 16.8 ±4.8 to 
15.5 ±4.4 L, but there was no change in intracellular water (ICW). Weight loss 
correlated positively with the change in ECW, but exceeded the fall in OH; mean 
bias -0.58  (95% confidence limits -3.6 to 4.8 kg). 
Summary 
  We measured OH pre-and post-haemodialysis, but did not find that the 
change in OH correlated with changes in body weight. Although there was a 
correlation between changes in OH and ECW, there was none for weight. Our 
findings do not support total reliance on pre-dialysis BIS alone for assessing 
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volume status in haemodialysis patients, but rather BIS should be considered as 
an aid to clinical assessment of volume status. 
 
Introduction 
 Despite the success of haemodialysis, with more than 2 million patients 
now treated world-wide, the mortality of haemodialysis patients remains high 
and is greater than that for some of the more common solid organ malignancies. 
Most deaths are cardiovascular in nature, with an increased risk of sudden 
deaths, thought to be due to dysrhythmias. For patients dialysing thrice weekly 
more haemodialysis patients are admitted to hospital or experience sudden 
death in the hours before the first dialysis session of the week, [1], when they 
most volume overloaded. As such achieving a target weight, when patients are no 
longer volume expanded, by achieving a normal extracellular water (ECW) volume 
has been reported to improve patient survival [2]. 
Bioimpedance devices estimate the amount of fluid in the body by 
measuring the electrical resistance to a series of alternating currents flowing 
between electrodes placed on the hand and foot [3,4].  There are a number of 
bioimpedance devices commercially available, they varying in the number of 
electrical frequencies and whether they measure body segments or total body 
[5,6]. Bioelectrical impedance spectroscopy (BIS) assessments of total body 
water (TBW), ECW and intracellular water (ICW) have been validated against 
“gold standard” isotopic methods [7]. In every day clinical practice BIS 
measurements are made pre-haemodialysis to determine ultrafiltration 
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requirements to achieve a normally hydrated status, or target weight post-
dialysis. Most bioimpedance devices have used a similar model to dual energy X 
ray absorptiometry (DXA) scanning, in terms of dividing the body into two basic 
compartments; fat mass and fat free mass, from which ICW and ECW are 
derived. However, for the dialysis patient it has been difficult to express the 
amount of excess fluid (over hydration (OH)) that a dialysis patient needs to 
lose to restore euvolaemia using this approach, with studies reporting ratios of 
ECW/TBW [8], or using equations to estimate ECW excess based on a normal 
ratio of ECW to ICW [9]. Newer BIS devices are now available, expressing OH, 
by using a 3 body compartmental approach, dividing lean body mass into normally 
hydrated tissue and the excess fluid as OH [3,7]. 
The assumption is that OH measured pre-dialysis provides information to 
guide the clinical team as to how much fluid should be during the dialysis session 
to return the patient to their target or post-dialysis weight. We therefore 
reviewed , pre and post dialysis bioimpedance measurements [10], to determine 
whether change in OH corresponded to the change in body weight following 
dialysis, to determine whether pre-dialysis measurement of OH by bioimpedance 
could be used to guide intra-dialytic weight loss. 
 
Methods 
 We audited the results of pre and post haemodialysis BIS measurements 
(BodyStat multiscan 5000, Douglas, Isle of Man). All haemodialysis sessions 
were performed with patients lying on a bed, and using Fresenius 4000H dialysis 
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machines (Fresenius MC, Bad Homburg, Germany), with a high flux dialyzer 
(Elisio, Nipro Corporation, Osaka, Japan) [11] anticoagulated with low molecular 
weight heparin (tinzaparin, Leo Laboratories, Princes Risborough, UK) [12], using 
ultra-pure quality dialysis water. Dialysis machines were regular serviced and 
dialysate sodium checked [13]. Dialysate bicarbonate was fixed at 32 mmol/L, 
with an acetate of 3.0 mmol/L and magnesium 0.5 mmol/L. Serum chemistries 
were measured pre-dialysis with a standard laboratory analyser (Roche Cobra 
II, Basingstoke, UK), by a UK accredited laboratory  
The amount of fluid to be removed during the dialysis session was 
determined by the clinical team, and if required ultrafiltration was set at a 
constant rate. Patients were restricted to one small drink during the dialysis 
session (approximately 180 ml) and no food was given. 
Bioimpedance measurements were made with the patient lying in bed. 
Four electrodes were placed according to the manufacturer’s instructions on the 
contra-lateral hand and wrist, ankle and dorsum of the foot to the arterio-
venous fistula. Electrodes remained in position for the course of the dialysis 
session, and for post dialysis measurements. The BIS device measures whole 
body resistance and reactance with 50 different alternating electrical current 
frequencies ranging from 5-1000 kHz. Due to different amount of water in body 
tissues, the BIS device computes ECW, ICW and from an estimation of normo-
hydrated tissues ECW excess as over hydration (OH) L. 
To allow time for re-equilibration post dialysis measurements were made 
after the fistula needle sites had stopped bleeding, patients had been re-
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weighed using the same scales, returned to bed and then rested. To ensure that 
patients were at a stable state, we repeated measurements up to four times in a 
number of patients. 
 
Statistical methods 
Statistical analysis was by parametric or non-parametric pair testing, 
ANOVA  with  appropriate post hoc testing, and univariate correlation, using 
Pearson or Spearman correlation (Prism 6.0, Graph Pad,  San Diego, USA), and 
Bland Altman analysis (version 3.0, Analyse It, Leeds, UK), with significance at 
the p<0.05 level. Data is reported as mean ± standard deviation, median and 
interquartile range or percentage. 
 
Ethics 
Standard clinical practice in our centre is to measure bioimpedance pre 
and post-dialysis as standard equipment uses a 2 compartmental model. We 
audited the results of pre and post haemodialysis BIS measurements made with 
bioimpedance device using a 3 compartmental model in consecutive patients to 
determine whether bioimpedance derived body composition should be measured 
pre or post dialysis to be the standard of care for routine clinical practice. 
Ethical approval fulfilled UK NHS clinical service development and audit (UK 
NHS guidelines for clinical audit and service development 
(http://www.hra.nhs.uk/documents /2013/09/ defining-research.pdf)).  
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Results 
Pre and corresponding post BIS measurements were retrospectively 
reviewed in in 49 consecutive adult patients receiving in-centre haemodialysis 
session who had corresponding pre and post dialysis session BIS measurements, 
35 male (71.4%), mean age 67.6 ±14.9 years, 22 Caucasoid (44.9%), 14 South 
Asian (28.6%), 7 African-Afro-Caribbean (14.3%) and 6 Far Asian (12.2%). 
Twenty two patients were diabetic (44.9%), and the median Davies co-morbidity 
score [14] was 2 (1-3). Pre-dialysis haemoglobin was 103.4±19.1 g/L, serum 
albumin 36.4±4.8 g/L, potassium 4.3±0.9 mmol/L, urea 18.4±6.2 mmol/L, calcium 
2.32±0.14 mmol/L, C reactive protein 8 (4-28) mg/L. 
Median dialysate sodium was 137 (136-138.5  mmol/L, potassium 2.0 (1-2) 
mmol/L, with a calcium 1.35 (1.0-1.35) mmol/L. Dialysate was cooled, median 
temperature 35.0 (35.0-35.5)oC.  The median dialyzer surface area was  2.1 (1.7-
2.1) m2.  
To ensure that patients were in a stable state when post dialysis BIS 
measurements were made, three sets of measurements were made after 38 of 
the dialysis sessions. There was no significant change by ANOVA in 
measurement of OH, ICW or ECW over time (table 1). In 12 patients, four 
separate measurements were made post-dialysis, to determine whether there 
was any change over time, and there were no differences noted between 
measurements (1st measurement ECW 17.0±4.6 vs 4th measurement 17.0±4.6 L; 
and ICW 17.0 ±5.6 vs 17.0 ±5.4 L, respectively). 
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Clinician notes of clinical volume assessments made pre-dialysis were 
reviewed and the patients assigned into 4 groups dehydrated, no overt clinical 
signs of ECW excess, pitting ankle oedema or elevated jugular venous pulsation, 
or gross ECW excess and clinical heart failure. OH measurements increased 
sequentially in these 4 groups from 3.05±0.07 (n=2), to 3.97±3.69 (n=16), 
4.29±2.8 (n=23) and finally 6.7±2.56 kg (n=8), in keeping with clinical assessment 
of increasing fluid retention.  As there were so few patients thought clinically to 
be dehydrated, we compared the group clinically thought to be euvolaemic and 
those with signs of ECW excess.  As clinical assessment of ECW excess 
increased, then so did OH measured by BIS, p <0.05 by ANOVA testing. Pre-
dialysis there was a correlation between OH and ECW (r=0.69, p<0.001), but not 
TBW (r=0.25, p=0.062) or ICW (r=-0.13, p=0.34).  
We compared the paired pre and post dialysis BIS measurements for 
each session, and as expected weight, and BIS measurements of TBW, ECW and 
OH fell significantly post dialysis (table 2). There was a simple correlation 
between the change in weight following dialysis with the change in TBW (r=0.55, 
p=0.03). We then compared the change in weight and TBW by Bland Altman 
analysis, which showed that the change in weight was greater than that in TBW, 
mean bias -0.03 (95% limit of agreement -8.2 to 8.1 L-kg) (Figure 1). However 
there was no significant correlation between the change in pre and post dialysis 
weight and OH ( r=-0.10, p=0.51).  
We then compared the change in patient weight and OH by Bland Altman 
analysis (Figure 2). Again, the difference in weight was greater than that for 
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OH following dialysis, mean bias 0.58 (95% limits of agreement -3.6 to 4.8. The 
change in weight with dialysis correlated with the change in ECW (r=0.44, 
p<0.01), but not with ICW (r=-0.18, p=0.70). The change in OH was positively 
associated with a change in ECW (r=0.31, p=0.03), and ratio of ECW/TBW 
(r=0.84, p<0.001) (Figure 3).   
To consider other factors which may have affected the change in ECW, 
we considered body size, in terms of weight and BMI. However there was no 
statistical association between body size pre-dialysis and the change in OH or 
change in the ratio of OH/ECW. Similarly there was no association with age, sex, 
diabetes or co-morbidity score. We did however find an association between the  
change in OH with the difference between pre-dialysis serum sodium and the 
dialysate sodium concentration t (r=0.43, p=0.02) and negatively with CRP (r=-
0.45, p<0.01). We also noted an association between  pre-dialysis serum sodium 
and dialysate sodium gradient and the change in ECW (r=0.73, p<0.001) but not 
with ICW. 
 
Discussion 
 One of the goals of haemodialysis treatment is to correct volume 
overload, and return patients to their target weight As such most patients would 
be expected to lose weight, with corresponding reductions in TBW, ECW and 
ICW [15]. We measured BIS pre and post dialysis sessions and compared the 
results from consecutive patients. A clinical decision was made in each case to 
determine the ultrafiltration target. We found a step wise increase in the mean 
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pre-dialysis assessment of volume status made by BIS and clinical assessment of 
volume status, and there was a positive correlation between pre-dialysis OH and 
ECW volume. 
 We chose to measure weight loss, rather than ultrafiltration rates or 
ultrafiltration measured by the dialysis machine to exclude errors in calculating 
volume loss due to fluid changes with connecting patients to the dialysis machine 
and differences in wash back at the end of the dialysis session. As expected, 
following dialysis there was a reduction in weight for the cohort. The weight loss 
was greater than both the change in TBW and OH. This is to be expected as 
normal plasma water has a higher density than water, and that from dialysis 
patients even greater due to the effects of urea and other azotaemic retention 
solutes. As such one litre of ultrafiltrate weighs more than 1.0 kg. However in 
calculating OH, it was assumed that one litre of OH was equivalent to one litre 
of water (1.0 kg) [3]. Although there was a correlation between the change in 
weight following dialysis and both ECW and TBW, but there was no statistical 
association with change in ICW. Other reports have noted that changes in skin 
temperature due to differences in local blood flow lead to changes in 
bioimpedance measurements, with cooling and vasoconstriction resulting in an 
increase in impedance, whereas vasodilatation reduced impedance [16]. However 
the algorithm used by the BIS is based on determining OH as being the amount 
of ECW excess for normally hydrated tissues, and as such ICW using this model 
would not be expected to change post-dialysis. However a recent study reported 
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removing sodium from tissues during dialysis [17], and as such this would be 
expected to cause changes in ICW. 
 Previous reports have suggested that using a lower dialysate sodium can 
lead to a greater reduction in ECW [18], and we also noted an association 
between the serum to dialysate sodium gradient with both the change in OH and 
ECW.   
 Our results, demonstrate  that the majority of change in OH is due to a 
change in ECW, which supports a previous report of using BIS and a 3 
compartmental body composition model [19,20]. As such pre-dialysis 
measurements of OH have been used to aid clinical decision making in terms of 
the amount of ultrafiltration required to return patients to a normo-volaemic 
state [21]. Most studies have only reported pre-dialysis measurements [20,22], 
and there has been an assumption that the pre-dialysis OH measurement was 
correct. However our data, although showing an increasing OH with clinical 
assessment of volume status  suggest that the actual measurement of OH pre-
dialysis should be used in conjunction with clinical assessment of volume status, 
and not replace clinical judgment. 
 Previous studies on BIS have reported on Caucasoid and African-
American haemodialysis patients [2,3,22], and we did have patients from other 
ethnic groups, and reports have suggested that some bioimpedance 
measurements may vary between ethnic groups, but not in terms of ECW status 
[23,24], and we also did not find any association with ethnicity. 
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 In theory post-dialysis bioimpedance measurements, could be affected by 
the electrolyte shifts occurring during the session [25].This effect has been 
thought to be of minimal clinical relevance by some groups [3], whereas others 
have suggested that the change in resistivity during the course of a 
haemodialysis session could potentially lead to an ECW change of around -3.2% 
to 1.4% and -3.7% to 1.7% for ICW. This would potentially introduce an error in 
estimating ICW of 20% or more, and a lower ECW error of less than 15% [25]. 
We did note an effect of CRP and the change in OH with dialysis.  
 Inflammatory conditions can lead to increased capillary permeability and 
ECW expansion [26], and as such this may affect the amount of fluid which can 
be readily removed during a dialysis session, in keeping with a negative 
association between CRP and change in OH.   
 We allowed time for changes in blood flow and electrolyte shifts to re-
equilibrate at the end of the dialysis session [27], and also the potential effect 
of a change in posture [28], so that when we repeated up to 4 measurements 
post-haemodialysis we found no significant differences. Unlike with some other 
BIS devices, the electrodes remained in place during the dialysis session [29], 
and no electrode had to be replaced, so eliminating error due to changes in 
electrode position.  
 Our retrospective audit has several limitations. There were a number of 
outlying data points, for the change in TBW, one patient was thought to be 
dehydrated pre-dialysis and had their weight increased with dialysis, and 
conversely another patient was thought to be markedly overhydrated and had a 
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large weight loss following dialysis. As this was an audit and not a study we do 
not have any comparative measurements of body volume by isotopic methods, or 
bioimpedance equipment, using a standard two body compartment model [4]. 
 Compared to standard bioimpedance devices [30], we have compared 
pre and post-haemodialysis measurements with a BIS device using a 3 body 
compartmental model determining fluid overload. Although there was a trend 
between clinical assessment of fluid overload and the OH measured by 
bioimpedance this was not significant. We observed that the change in patient 
weight did not correlate with the measured changes in OH, or ICW. Weight 
change was predominantly related to changes in ECW. Previous studies targeting 
weight loss according to pre-dialysis BIS measurements have reported 
premature loss of residual renal function [31]. As such we would suggest that 
pre-dialysis BIS determination of OH should be used in conjunction with clinical 
assessments of volume status, and not replace clinical judgment, particularly for 
patients with evidence of systemic inflammation. 
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Figure 1.Bland Altman plot of the change in patient weight (Wt) (kg) and total 
body water (TBW) (litres) following haemodialysis. . Mean bias and 95% 
confidence limits are depicted as dotted lines. 
 
  
Figure 2. Bland Altman plot of the change in patient weight (Wt) (kg) and over 
hydration index (OH) L following haemodialysis. Mean bias and 95% confidence 
limits are depicted as dotted lines. 
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Figure 3. Relationship between change in the ratio of extracellular water (ECW) 
to total body water (TBW) and change in over hydration index (OH) following 
haemodialysis 
 
 
Table 1. Reproducibility of post-haemodialysis bioimpedance spectroscopy 
derived measurements of over hydration (OH), extracellular water (ECW) and 
intracellular water (ICW). There were no significant differences between the 3 
measurements in 38 patients. 
measurement Over hydration  Extracellular water Intracellular water 
first 3.71±2.95  kg 15.60±4.48 L 14.85±4.62 L 
second 3.72±2.96 kg 15.61±4.48 L 14.90±4.63 L 
third 3.66±2.96 kg 15.58±4.48 L 14.99±4.65 L 
 
 
 
Table2: Pre and post haemodialysis session weight and volume assessments made 
by bioimpedance spectroscopy. Values expressed as mean ± standard deviation 
. 
variable Pre dialysis Post dialysis p value 
Weight kg 69.2±17.8 67.6±17.4 <0.001 
 18 
Over hydration kg 4.5±3.4  3.4±2.9  <0.01 
Total body water L 31.2 ±9.9 30.5 ±8.4 <0.001 
Extracellular water L 16.8 ±4.8 15.5 ±4.4 <0.001 
Intracellular water L 15.4 ±6.4 15.0 ±4.8 0.47 
 
